Literature DB >> 17760753

The protective effect of darbepoetin alfa on experimental testicular torsion and detorsion injury.

Bulent Akcora1, Muhammed Enes Altug, Tunay Kontas, Esin Atik.   

Abstract

AIM: Testicular torsion is a serious urological emergency, usually involving newborns, children, and adolescents which can lead to subfertility and infertility. Prevention of testicular damage caused by torsion is still a clinical and experimental problem. So far many chemicals and drugs have been investigated for decreasing ischemia/reperfusion (I/R) injury in experimental animals. The possible protective effect of darbepoetin alfa, a novel erythropoietic protein, on testicular tissue after I/R injury was examined in this study.
METHODS: Thirty rats were divided into three groups: sham operation, torsion/detorsion, and torsion/detorsion plus darbepoetin alfa groups. After torsion (2 hours) and detorsion (4 hours), bilateral orchiectomy was performed. Malondialdehyde, nitric oxide and glutathione levels were determined in testicular tissue.
RESULTS: Administration of darbepoetin alfa caused a decrease of malondialdehyde and nitric oxide levels and an increase in glutathione levels compared with the torsion/detorsion group. In addition, histological injury scores were significantly decreased in the treatment group more than the torsion/detorsion group.
CONCLUSION: The results suggest that darbepoetin alfa may be a potential protective agent for preventing testicular injury caused by testis torsion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17760753     DOI: 10.1111/j.1442-2042.2007.01844.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  7 in total

1.  Medical perspective in testicular ischemia-reperfusion injury.

Authors:  Salvatore Arena; Roberta Iacona; Pietro Antonuccio; Tiziana Russo; Vincenzo Salvo; Eloisa Gitto; Pietro Impellizzeri; Carmelo Romeo
Journal:  Exp Ther Med       Date:  2017-03-30       Impact factor: 2.447

2.  Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway.

Authors:  Letteria Minutoli; Alessandra Bitto; Francesco Squadrito; Natasha Irrera; Mariagrazia Rinaldi; Piero Antonio Nicotina; Salvatore Arena; Carlo Magno; Herbert Marini; Luca Spaccapelo; Alessandra Ottani; Daniela Giuliani; Carmelo Romeo; Salvatore Guarini; Pietro Antonuccio; Domenica Altavilla
Journal:  Endocrinology       Date:  2011-08-09       Impact factor: 4.736

3.  Comparison of erythropoietin and sildenafil protective role against ischemia/reperfusion injury of the testis in adult rats.

Authors:  Nick Zavras; Ioannis D Kostakis; Stratigoula Sakellariou; Christos Damaskos; Evangelos Roupakas; Eleni Tsagkari; Eleftherios Spartalis; Konstantinos Velaoras; Ismene A Dontas; Theodore Karatzas
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

4.  The protective effect of erythropoietin infusion on testicular torsion/detorsion: an experimental study.

Authors:  Burhan Köseoğlu; Engin Yilmaz; Kadir Ceylan; Ersan Uzun; Irfan Bayram; Fatih Hizli
Journal:  Int Urol Nephrol       Date:  2008-07-15       Impact factor: 2.370

5.  Erythropoietin and sildenafil protect against ischemia/reperfusion injury following testicular torsion in adult rats.

Authors:  Ioannis D Kostakis; Nick Zavras; Christos Damaskos; Stratigoula Sakellariou; Penelope Korkolopoulou; Evangelos P Misiakos; Petros Tsaparas; George Vaos; Theodoros Karatzas
Journal:  Exp Ther Med       Date:  2017-05-08       Impact factor: 2.447

6.  The effect of erythropoietin on ischemia/reperfusion injury after testicular torsion/detorsion: a randomized experimental study.

Authors:  Fahimeh Kazemi Rashed; Babollah Ghasemi; Hamid Deldade Mogaddam; Mehran Mesgari
Journal:  ISRN Urol       Date:  2013-03-31

7.  Antioxidant and antiapoptotic effects of darbepoetin-α against traumatic brain injury in rats.

Authors:  Hayri Kertmen; Bora Gürer; Erdal Resit Yilmaz; Mehmet Ali Kanat; Ata Türker Arikok; Berrin Imge Ergüder; Askin Esen Hasturk; Julide Ergil; Zeki Sekerci
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.